Injectable bladder muscle cells-polymer suspension for treatment of vesicoureteral reflux and incontinence
US5976526A · kind A · utility
32Cited by
5References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 28, 1997 |
| Grant date | Nov 2, 1999 |
| Priority date | — |
| Expiry date | Aug 28, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2400/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treatment of vesicoureteral reflux, incontinence and other defects is described wherein bladder muscle cells are mixed with a liquid polymeric material to form a suspension. This is injected into the area of the defect, in an amount effective to yield a muscle area that provides the required control over the passage of urine or otherwise corrects the defect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.